The University of North Carolina at Chapel Hill says a team of scientists have developed a treatment, called EIDD-2801, which may reduce lung damage in patients suffering from COVID-19.
The study suggests that stimulating the brain at a gamma frequency of 40 Hz can trigger a series of beneficial effects that help reduce harmful protein levels.